CPI Card Group Inc. (PMTS)·Q2 2025 Earnings Summary
Executive Summary
- Q2 net sales grew 9% to $129.8M (15% ex one-time accounting change); Adjusted EBITDA rose 3% to $22.5M while diluted EPS fell to $0.04 as acquisition, restructuring, higher interest, and tariff/mix pressures weighed on GAAP earnings .
- Guidance: 2025 net sales growth raised to low double-digit to mid-teens; Adjusted EBITDA growth outlook maintained at mid-to-high single digits; outlook excludes proposed chip tariffs announced Aug 6 .
- Consensus context: Q2 missed Wall Street on revenue ($129.8M vs $133.0M est*) and EPS ($0.04 vs $0.50 est*); EBITDA also trailed ($14.9M vs $23.7M est*). Management noted tariffs and dual-facility transition costs as headwinds, with Arroweye outperforming early .
- Key drivers/catalysts: Arroweye delivered
$10M revenue in <2 months and is tracking above expectations; tariff headwinds ($5M 2025) and ~$3M duplicative costs from facility transition; narrative hinges on executing Arroweye synergies, Card@Once growth, and clarity on chip tariffs .
What Went Well and What Went Wrong
-
What Went Well
- Arroweye acquisition outperformed early: “Arroweye delivering approximately $10 million of net sales in less than 2 months,” with customer feedback strong and synergy plans under way .
- Card@Once and contactless (incl. metal) drove Debit & Credit strength; segment net sales +16% YoY to $110.8M (18% ex accounting change) .
- Management raised full-year net sales outlook on Arroweye contribution while reaffirming secular demand (Visa/Mastercard U.S. cards in circulation +8% 3-yr CAGR) .
-
What Went Wrong
- Gross margin compressed to 30.9% (from 35.7%) on mix, tariffs, depreciation, and facility transition costs; gross profit -5% YoY to $40.1M .
- Prepaid Debit net sales fell 19% to $19.2M on reported basis (would be +4% ex accounting change), pressuring consolidated mix and margins .
- GAAP earnings headwinds: diluted EPS $0.04 (down 91%) with acquisition/integration and restructuring charges and higher interest expense; consensus EPS and revenue misses underscore magnitude of non-GAAP/temporary headwinds* [GetEstimates Q2 2025*].
Financial Results
Q2 actual vs S&P Global consensus (Q2 2025)
Values retrieved from S&P Global for consensus and related surprises.
Segment performance (Net Sales)
Select KPIs and balance sheet
Non-GAAP/accounting change note: In Q2 the company shifted certain WIP revenue from over-time to point-in-time recognition, creating a one-time, non-cash negative timing impact (~$7.7–$8.0M) to reported Q2 revenue and GAAP profitability; cash flow and Adjusted EBITDA were not impacted .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO John Lowe: “We are excited about Arroweye’s performance and continued growth from our portfolio of payment solutions, with especially strong momentum from our SaaS-based instant issuance solution” .
- CEO John Lowe: “Our other strategic investments in healthcare payments, the closed-loop Prepaid business, and digital solutions are also creating incremental growth opportunities… while investment in our new production facility should provide increased capacity, capabilities, and efficiencies” .
- CFO Jeff Hochstadt: “We’re pleased with the growth… while… managing operating expenses tightly to help counter gross margin pressures, including the impact of tariffs… We plan to utilize future free cash flow over time to drive down net leverage” .
- CFO elaboration on call: tariffs expected to be about $5M for 2025; dual production facilities introduce ~$3M incremental costs this year (transition), with efficiencies expected thereafter .
Q&A Highlights
- Tariffs and cost headwinds: Management quantified FY25 tariff expense at ~$5M, with >$1M in Q2; mitigation efforts include partnering with customers and operational efficiencies .
- Facility transition costs: Indiana facility ramp driving ~$(3)M duplicative costs in 2025; efficiencies expected as operations consolidate .
- Arroweye: Early contribution near $10M revenue in <2 months and better-than-expected profitability; synergy capture a focus .
- Prepaid/closed-loop: Secured customer commitments for closed-loop prepaid packages; first deliveries targeted for Q4, supporting FY trajectory despite Q2 reporting impacts from accounting change .
- Outlook clarity: Guidance excludes proposed chip tariffs pending details; company cites ample chip inventories and stable macro assumption .
Estimates Context
- Q2 vs consensus: Revenue miss (~$129.8M vs $133.0M est*), EPS miss ($0.04 vs $0.50 est*), EBITDA miss ($14.9M vs $23.7M est*). The gap reflects non-cash accounting timing (WIP), acquisition/integration and restructuring charges, tariffs, and higher interest, with Adjusted EBITDA holding firmer than GAAP EBITDA [GetEstimates Q2 2025*].
- Estimate revision setup: Raised sales outlook (Arroweye contribution) vs margin headwinds (tariffs/mix/depreciation and transition) suggest near-term EPS/EBITDA estimate pressure until cost headwinds abate and synergies/efficiencies materialize .
Values retrieved from S&P Global for consensus and surprise metrics (marked with *).
Key Takeaways for Investors
- Mix/tariff-driven margin compression masked solid demand; Adjusted EBITDA growth (+3%) alongside a large GAAP EPS decline highlights the importance of focusing on non-GAAP drivers near term .
- Arroweye is outperforming early and lifted the FY sales guide; synergy capture and cross-sell into CPI’s FI base are key to re-accelerating profit growth in 2026+ .
- Prepaid weakness is largely timing/accounting; underlying demand (ex accounting change) shows growth, with closed-loop packaging deliveries slated for Q4 .
- Cost headwinds (~$5M tariffs; ~$3M dual-facility costs FY25) should moderate as the new plant ramps and mitigation actions flow through; watch gross margin trajectory each quarter .
- Balance sheet: Net leverage at 3.6x after Arroweye; post-quarter $20M note redemption supports gradual deleveraging as FCF improves with lower capex and normalized working capital .
- Catalysts: tariff policy clarity (chip tariffs), facility transition milestones, Arroweye synergy updates, and Q4 closed-loop execution; these will drive estimate revisions and stock narrative .
Appendix: Additional Context
- Prior quarters snapshot: Q4’24 revenue $125.1M, Adj. EBITDA $21.9M; Q1’25 revenue $122.8M, Adj. EBITDA $21.2M; Q2’25 revenue $129.8M, Adj. EBITDA $22.5M, showing resilient top line and stable adjusted profitability despite GAAP margin headwinds .
- Accounting change detail: shift from over‑time to point‑in‑time for certain WIP orders created a one-time, non-cash negative Q2 revenue/GAAP earnings impact (~$7.7–$8.0M); does not affect cash or Adjusted EBITDA .
Sources: PMTS Q2’25 press release and exhibits; Q2’25 8‑K and investor presentation; Q1’25 and Q4’24 press releases; third‑party transcripts/highlights for Q&A items where internal transcript retrieval was unavailable.
and external: .